Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy
Julie Doan(Jewish General Hospital), Cara Tannenbaum(Université de Montréal), Hubert Zakrzewski-Jakubiak(Université de Montréal), Jacques Turgeon(Académie Nationale de Médecine), Julie Roy(Jewish General Hospital)
Cited by 186
Related Papers
Sex and gender analysis improves science and engineering
|Nature|2019|579
Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
|Pharmaceutics|2020|237
Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.
|PubMed|1999|177